Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013 (2013), Article ID 642964, 15 pages
http://dx.doi.org/10.1155/2013/642964
Research Article

Proteomic Profiling for Peritoneal Dialysate: Differential Protein Expression in Diabetes Mellitus

1Department of Chemical and Materials Engineering, National Yunlin University of Science and Technology, Yunlin 640, Taiwan
2Department of Nephrology, Chi-Mei Medical Center, Tainan 710, Taiwan
3Department of Sport Management, College of Leisure and Recreation Management, Chia Nan University of Pharmacy and Science, Tainan 717, Taiwan
4Department of Biochemistry, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
5Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan
6Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
7Department of Chemistry, National Sun Yat-Sen University, Kaohsiung 804, Taiwan
8National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center, Kaohsiung 807, Taiwan
9Department of Family Medicine, Chi-Mei Medical Center, Tainan 710, Taiwan
10Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, 100 Shi-Chuan 1st Road, Kaohsiung 807, Taiwan

Received 22 March 2013; Accepted 9 May 2013

Academic Editor: Visith Thongboonkerd

Copyright © 2013 Ming-Hui Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. N. Schilte, J. W. A. M. Celie, P. M. Ter Wee, R. H. J. Beelen, and J. van den Born, “Factors contributing to peritoneal tissue remodeling in peritoneal dialysis,” Peritoneal Dialysis International, vol. 29, no. 6, pp. 605–617, 2009. View at Google Scholar · View at Scopus
  2. R. Paniagua, D. Amato, E. Vonesh et al., “Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial,” Journal of the American Society of Nephrology, vol. 13, no. 5, pp. 1307–1320, 2002. View at Google Scholar · View at Scopus
  3. C. J. Holmes and D. Faict, “Peritoneal dialysis solution biocompatibility: definitions and evaluation strategies,” Kidney International, vol. 64, supplement 88, pp. S50–S56, 2003. View at Google Scholar · View at Scopus
  4. S. J. Davies, J. Bryan, L. Phillips, and G. I. Russell, “Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis,” Nephrology Dialysis Transplantation, vol. 11, no. 3, pp. 498–506, 1996. View at Google Scholar · View at Scopus
  5. E. T. Pride, J. Gustafson, A. Graham et al., “Comparison of a 2.5% and a 4.25% dextrose peritoneal equilibration test,” Peritoneal Dialysis International, vol. 22, no. 3, pp. 365–370, 2002. View at Google Scholar · View at Scopus
  6. D. Maksic, S. Vasilijic, M. Colic, V. Stankovic-Popovic, and D. Bokonjic, “Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis,” Advances in Peritoneal Dialysis, vol. 25, pp. 50–55, 2009. View at Google Scholar · View at Scopus
  7. R. Raaijmakers, W. Pluk, C. H. Schröder et al., “Proteomic profiling and identification in peritoneal fluid of children treated by peritoneal dialysis,” Nephrology Dialysis Transplantation, vol. 23, no. 7, pp. 2402–2405, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Sritippayawan, W. Chiangjong, T. Semangoen et al., “Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes,” Journal of Proteome Research, vol. 6, no. 11, pp. 4356–4362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. P. J. J. Hegmans, J. D. Veltman, E. T. Fung et al., “Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS,” Technology in Cancer Research and Treatment, vol. 8, no. 5, pp. 323–332, 2009. View at Google Scholar · View at Scopus
  10. Y. C. Tyan, H. Y. Wu, W. W. Lai, W. C. Su, and P. C. Liao, “Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry,” Journal of Proteome Research, vol. 4, no. 4, pp. 1274–1286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. C. Tyan, M. H. Yang, T. W. Chung, C. Y. Lu, W. C. Tsai, and S. B. Jong, “Assessing human urinary proteome using a mass spectrometry-based profiling system combined with magnetic nanoparticles,” Clinica Chimica Acta, vol. 420, pp. 54–61, 2013. View at Publisher · View at Google Scholar
  12. Y. C. Tyan, M. H. Yang, S. C. Chen et al., “Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma,” Rapid Communications in Mass Spectrometry, vol. 25, no. 19, pp. 2851–2862, 2011. View at Publisher · View at Google Scholar
  13. A. Brauner, O. Hertting, E. Alkstrand et al., “CAPD peritonitis induces the production of a novel peptide, daintain/allograft inflammatory factor-1,” Peritoneal Dialysis International, vol. 23, no. 1, pp. 5–13, 2003. View at Google Scholar · View at Scopus
  14. H. Y. Wang, Y. F. Tian, C. C. Chien et al., “Differential proteomic characterization between normal peritoneal fluid and diabetic peritoneal dialysate,” Nephrology Dialysis Transplantation, vol. 25, no. 6, pp. 1955–1963, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. C. Tyan, S. B. Su, S. S. Ting, H. Y. Wang, and P. C. Liao, “A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry,” Clinica Chimica Acta, vol. 420, pp. 34–44, 2013. View at Publisher · View at Google Scholar
  16. Y. C. Tyan, H. Y. Wu, W. C. Su, P. W. Chen, and P. C. Liao, “Proteomic analysis of human pleural effusion,” Proteomics, vol. 5, no. 4, pp. 1062–1074, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. H. Yang, Y. H. Yang, C. Y. Lu et al., “Activity-dependent neuroprotector homeobox protein: a candidate protein identified in serum as diagnostic biomarker for Alzheimer's disease,” Journal of Proteomics, vol. 75, no. 12, pp. 3617–3629, 2012. View at Publisher · View at Google Scholar
  18. J. D. Jaffe, H. C. Berg, and G. M. Church, “Proteogenomic mapping as a complementary method to perform genome annotation,” Proteomics, vol. 4, no. 1, pp. 59–77, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Y. Wang, C. Y. Lin, C. C. Chien et al., “Impact of uremic environment on peritoneum: a proteomic view,” Journal of Proteomics, vol. 75, no. 7, pp. 2053–2063, 2012. View at Publisher · View at Google Scholar
  20. M. H. Yang, Y. C. Tyan, S. B. Jong, Y. F. Huang, P. C. Liao, and M. C. Wang, “Identification of human hepatocellular carcinoma-related proteins by proteomic approaches,” Analytical and Bioanalytical Chemistry, vol. 388, no. 3, pp. 637–643, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. B. L. Verges, L. Lagrost, G. Veillant, J. M. Brun, A. Goux, and P. Gambert, “Apolipoprotein A-IV levels and phenotype distribution in NIDDM,” Diabetes Care, vol. 17, no. 8, pp. 810–817, 1994. View at Publisher · View at Google Scholar
  22. B. Verges, “Apolipoprotein A-IV in diabetes mellitus,” Diabete et Metabolisme, vol. 21, no. 2, pp. 99–105, 1995. View at Google Scholar · View at Scopus
  23. B. Kollerits, V. Krane, C. Drechsler et al., “Apolipoprotein A-IV concentrations and clinical outcomes in hemodialysis patients with type 2 diabetes mellitus-a post hoc analysis of the 4D study,” Journal of Internal Medicine, vol. 272, no. 6, pp. 592–600, 2012. View at Publisher · View at Google Scholar
  24. D. Quilliot, E. Walters, B. Guerci et al., “Effect of the inflammation, chronic hyperglycemia, or malabsorption on the apolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis,” Metabolism, vol. 50, no. 9, pp. 1019–1024, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. P. H. Hung, Y. C. Lu, Y. W. Chen et al., “Proteomic identification of plasma signatures in type 2 diabertic nephropathy,” Journal of Integrated OMICS, vol. 1, pp. 151–156, 2011. View at Google Scholar
  26. L. Rohrer, M. Hersberger, and A. Von Eckardstein, “High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease,” Current Opinion in Lipidology, vol. 15, no. 3, pp. 269–278, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. R. X. Li, H. B. Chen, K. Tu et al., “Localized-statistical quantification of human serum proteome associated with type 2 diabetes,” PLoS One, vol. 3, no. 9, Article ID e3224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Liu, Q. Feng, Y. Chen et al., “Proteomics-based identification of differentially-expressed proteins including galectin-1 in the blood plasma of type 2 diabetic patients,” Journal of Proteome Research, vol. 8, no. 3, pp. 1255–1262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. A. A. Rao, G. R. Sridhar, and U. N. Das, “Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease,” Medical Hypotheses, vol. 69, no. 6, pp. 1272–1276, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Sasaki, T. Iwasaki, S. Kato, and N. Tada, “High retinol/retinol-binding protein ratio in noninsulin-dependent diabetes mellitus,” American Journal of the Medical Sciences, vol. 310, no. 5, pp. 177–182, 1995. View at Google Scholar · View at Scopus
  31. T. F. Chan, H. S. Chen, Y. C. Chen et al., “Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus,” Reproductive Sciences, vol. 14, no. 2, pp. 169–174, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Krill, L. O. ’leary, A. N. Koehler et al., “Association of retinol binding protein in multiple-case families with insulin-dependent diabetes,” Human Biology, vol. 69, no. 1, pp. S89–S96, 1997. View at Google Scholar
  33. T. K. Basu, W. J. Tze, and J. Leichter, “Serum vitamin A and retinol-binding protein in patients with insulin-dependent diabetes mellitus,” American Journal of Clinical Nutrition, vol. 50, no. 2, pp. 329–331, 1989. View at Google Scholar · View at Scopus
  34. R. M. Baena, C. Campoy, R. Bayés, E. Blanca, J. M. Fernández, and J. A. Molina-Font, “Vitamin A retinol binding protein and lipids in type 1 diabetes mellitus,” European Journal of Clinical Nutrition, vol. 56, no. 1, pp. 44–50, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. C. C. Chen, J. Y. Wu, C. T. Chang et al., “Levels of retinol-binding protein 4 and uric acid in patients with type 2 diabetes mellitus,” Metabolism, vol. 58, no. 12, pp. 1812–1816, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Gohda, Y. Makita, T. Shike et al., “Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a type 2 diabetes model: is Zn-α2 glycoprotein-1 a candidate gene for obesity?” Diabetes, vol. 52, no. 8, pp. 2175–2181, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Shore, R. Khurshid, and M. Saleem, “Alpha-1 microglobukin: a marker for early detection of tubular disorders in diabetic nephropathy,” Journal of Ayub Medical College, Abbottabad, vol. 22, pp. 53–55, 2010. View at Google Scholar
  38. S. Riaz, S. S. Alam, S. K. Srai, V. Skinner, A. Riaz, and M. W. Akhtar, “Proteomic identification of human urinary biomarkers in diabetes mellitus type 2,” Diabetes Technology and Therapeutics, vol. 12, no. 12, pp. 979–988, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Riaz, V. Skinner, and S. K. Srai, “Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2,” Journal of Pharmaceutical and Biomedical Analysis, vol. 54, no. 4, pp. 817–825, 2011. View at Publisher · View at Google Scholar
  40. P. Ruggenenti, A. Fassi, A. P. Ilieva et al., “Preventing microalbuminuria in type 2 diabetes,” New England Journal of Medicine, vol. 351, no. 19, pp. 1941–1951, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. B. J. Tepper, Y. K. Kim, V. Shete, E. Shabrova, and L. Quadro, “Serum Retinol-Binding Protein 4 (RBP4) and retinol in a cohort of borderline obese women with and without gestational diabetes,” Clinical Biochemistry, vol. 43, no. 3, pp. 320–323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. O. P. Bondar, D. R. Barnidge, E. W. Klee, B. J. Davis, and G. G. Klee, “LC-MS/MS quantification of Zn-α2 glycoprotein: a potential serum biomarker for prostate cancer,” Clinical Chemistry, vol. 53, no. 4, pp. 673–678, 2007. View at Publisher · View at Google Scholar · View at Scopus